HAVCR2 and neoplasm: For example, TIM-3 has been reported to suppress nucleic acid-mediated innate immune responses in tumour-infiltrating dendritic cells (DCs)9, whereas TIM-3 promotes lipopolysaccharide-induced DC activation8.